Skip to main content
Clinical Trials/NCT00627406
NCT00627406
Completed
Phase 4

A Prospective Randomised Study to Evaluate the Effect of Triggering Ovulation With GnRHa (Buserelin) and Low Dose hCG (Pregnyl) as Compared to the Use of Conventional Doses of hCG (Pregnyl)

Regionshospitalet Viborg, Skive1 site in 1 country384 target enrollmentJanuary 2009

Overview

Phase
Phase 4
Intervention
Buserelin and Pregnyl
Conditions
OHSS (Ovarian Hyperstimulation)
Sponsor
Regionshospitalet Viborg, Skive
Enrollment
384
Locations
1
Primary Endpoint
Frequency of Moderate to Severe OHSS.
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study is to possibly further improve the clinical outcome and explore the incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in GnRH antagonist IVF/ICSI cycles

Registry
clinicaltrials.gov
Start Date
January 2009
End Date
December 2011
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Regionshospitalet Viborg, Skive
Responsible Party
Principal Investigator
Principal Investigator

Peter Humaidan

Prof. M.D. D.M.Sc.

Regionshospitalet Viborg, Skive

Eligibility Criteria

Inclusion Criteria

  • Patient complying with the conditions for IVF or ICSI treatment
  • Female age over 20 years and under 40 years
  • Normal regular cycle and patients with oligomenorrhea
  • BMI \> 18 and \< 35
  • each patient contributes with one cycle only

Exclusion Criteria

  • Significant disturbances in the woman (diabetes, epilepsy, liver/renal/heart disease, metabolic disorder)
  • Patients with \> 25 follicles on the day of triggering ovulation

Arms & Interventions

A

More than 14 follicles with a diameter of \> 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl)

Intervention: Buserelin and Pregnyl

B

More than 14 follicles with a diameter of \> 11mm: triggering of ovulation with hCG (Pregnyl) 5.000 IU (s.c.)

Intervention: Pregnyl

C

14 or less follicles with a diameter of \> 11mm: triggering of ovulation with 0.5 mg GnRHa (Buserelin) (s.c.) + 1500 IU hCG (Pregnyl) (s.c.) at 35 hours and 1500 IU hCG (Pregnyl) (s.c.) 7 days after triggering of ovulation (OPU + 5)

Intervention: Buserelin and Pregnyl

D

14 or less follicles with a diameter of \> 11mm: triggering of ovulation with 5000 IU hCG (Pregnyl) (s.c.)

Intervention: Pregnyl

Outcomes

Primary Outcomes

Frequency of Moderate to Severe OHSS.

Time Frame: From the date of triggering ovulation until 2 weeks after pregnancy test. group C and D. 12 days after pregnancy test

Secondary Outcomes

  • Pregnancy Rate(from stimulation day 1 until last ultrasound scan 7 weeks after a positive pregnancy test)

Study Sites (1)

Loading locations...

Similar Trials